What is the detailed management and recommended diagnostic workup for biopsy‑proven histoplasmosis involving the adrenal gland?

Biopsy-Proven Adrenal Histoplasmosis: Management and Workup

For biopsy-proven histoplasmosis involving the adrenal gland, you should treat this as disseminated disease with liposomal amphotericin B (3.0 mg/kg daily) for 1–2 weeks, followed by itraconazole (200 mg three times daily for 3 days, then 200 mg twice daily) for at least 12 months 1.

Understanding Adrenal Histoplasmosis

Adrenal involvement represents disseminated histoplasmosis, which can occur in both immunocompromised and immunocompetent hosts 2, 3. The adrenal glands are a recognized site of dissemination, and bilateral involvement frequently leads to primary adrenal insufficiency requiring lifelong glucocorticoid replacement 3, 4.

Key Clinical Context

• Adrenal histoplasmosis often mimics malignancy or other granulomatous diseases on imaging 2
• Constitutional symptoms (fever, weight loss, fatigue) are common 3, 4
• Hyponatremia may be the presenting laboratory abnormality 3
• Pulmonary nodules are frequently present even without respiratory symptoms 3, 4

Treatment Algorithm

Initial Therapy (Weeks 1-2)

For moderately severe to severe disease:

• Liposomal amphotericin B 3.0 mg/kg daily for 1–2 weeks 1
• Alternative: Other lipid formulations at 5.0 mg/kg daily may be used based on cost or tolerability 1
• Alternative: Amphotericin B deoxycholate (0.7–1.0 mg/kg daily) only if low nephrotoxicity risk 1

For mild-to-moderate disease:

• You can proceed directly to itraconazole (see below) 1

Consolidation/Maintenance Therapy (Months 1-12+)

• Itraconazole 200 mg three times daily for 3 days (loading dose)
• Then 200 mg twice daily for at least 12 months 1

Special Considerations

If immunosuppressed and immunosuppression cannot be reversed:

• Lifelong suppressive therapy with itraconazole 200 mg daily may be required 1

If relapse occurs despite appropriate therapy:

• Consider lifelong suppressive therapy 1

Essential Diagnostic Tests

Baseline Assessment

Adrenal function testing (critical):

• Morning serum cortisol
• ACTH level
• Cosyntropin stimulation test to confirm primary adrenal insufficiency 3
• Electrolytes (look for hyponatremia, hyperkalemia)

Extent of disease evaluation:

• Chest CT to assess for pulmonary involvement 3, 4
• Consider 18F-FDG PET/CT to detect other sites of dissemination and guide biopsy targets 2
• Abdominal imaging (CT or MRI) to characterize adrenal lesions

Microbiological confirmation:

• Histoplasma urine antigen (highly sensitive for disseminated disease)
• Histoplasma serum antigen
• Complement fixation antibodies for H. capsulatum 1
• Blood and urine cultures for Histoplasma (if available)

Immune status:

• HIV testing with CD4 count
• Assessment of other immunosuppressive conditions

Monitoring During Treatment

Therapeutic drug monitoring:

• Itraconazole blood levels should be obtained to ensure adequate drug exposure 1
• Target trough level typically >1.0 mcg/mL

Disease activity monitoring:

• Histoplasma antigen levels (urine and serum) should be measured during therapy and for 12 months after therapy ends to monitor for relapse 1
• Note: Persistent low-level antigenuria may not require treatment prolongation if therapy is complete and no active infection evidence exists 1

Adrenal function:

• Repeat cortisol/ACTH testing after antifungal therapy completion
• Most patients require lifelong glucocorticoid replacement despite successful antifungal treatment 3, 5

Critical Management Pitfalls

Common Errors to Avoid

1. Mistaking for malignancy: Adrenal histoplasmosis mimics metastatic disease radiologically—always consider fungal infection in endemic areas or with exposure history 2, 4

2. Inadequate treatment duration: The minimum is 12 months; shorter courses lead to relapse 1

3. Failing to check itraconazole levels: Drug absorption varies significantly; therapeutic monitoring is essential 1

4. Stopping antigen monitoring too early: Continue for 12 months post-treatment to detect relapse 1

5. Assuming adrenal function will recover: Most patients need permanent glucocorticoid replacement even after successful antifungal therapy 3, 5

6. Missing immunosuppression: Always evaluate for HIV and other immunocompromising conditions, as these patients may need lifelong suppressive therapy 1

Severity Assessment

Classify as severe if:

• Hypotension or shock
• Respiratory failure
• Multiple organ involvement
• Significant adrenal insufficiency symptoms

Classify as mild-to-moderate if:

• Stable vital signs
• No respiratory compromise
• Localized disease with manageable symptoms

Adjunctive Therapy

Glucocorticoid replacement (essential):

• Initiate hydrocortisone 15-25 mg daily in divided doses (or equivalent)
• Fludrocortisone 0.05-0.2 mg daily if mineralocorticoid deficiency present
• Stress dose steroids during acute illness

In immunocompromised patients:

• If HIV-positive with CD4 <150 cells/mm³, continue itraconazole prophylaxis until CD4 >150 cells/mm³ on antiretroviral therapy 1